Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis

Corpechot, C; Chazouilleres, O; Belnou, P; Montano-Loza, AJ; Mason, A; Ebadi, M; Eurich, D; Chopra, S; Jacob, D; Schramm, C; Sterneck, M; Bruns, T; Reuken, P; Rauchfuss, F; Roccarina, D; Thorburn, D; Gerussi, A; Trivedi, P; Hirschfield, G; McDowell, P; Nevens, F; Boillot, O; Bosch, A; Giostra, E; Conti, F; Poupon, R; Pares, A; Reig, A; Donato, MF; Malinverno, F; Floreani, A; Russo, FP; Cazzagon, N; Verhelst, X; Goet, J; Harms, M; van Buuren, H; Hansen, B; Carrat, F; Dumortier, J

Corpechot, C (corresponding author), Sorbonne Univ, Inserm UMR S938, St Antoine Res Ctr, 184 Rue Faubourg St Antoine, F-75571 Paris 12, France.; Corpechot, C (corresponding author), St Antoine Hosp, AP HP, Reference Ctr Inflammatory Biliary Dis & Autoimmu, 184 Rue Faubourg St Antoine, F-75571 Paris 12, France.

JOURNAL OF HEPATOLOGY, 2020; 73 (3): 559

Abstract

Background & Aims: Recurrence of primary biliary cholangitis (PBC) after liver transplantation (LT) is frequent and can impair graft and patient s......

Full Text Link